|
US570561A
(en)
|
|
1896-11-03 |
|
S peters co |
|
US2808035A
(en)
|
1953-04-23 |
1957-10-01 |
Riley Stoker Corp |
Burning wet materials
|
|
JPS5623587A
(en)
|
1979-08-03 |
1981-03-05 |
Mitsuwa Seiki Co Ltd |
Vane type compressor
|
|
JPS58110600A
(ja)
|
1981-12-25 |
1983-07-01 |
Kyowa Hakko Kogyo Co Ltd |
ヒトβ型インタ−フエロン遺伝子を含む組みかえ体プラスミド
|
|
WO1985003934A1
(fr)
|
1984-03-06 |
1985-09-12 |
Takeda Chemical Industries, Ltd. |
Proteine modifiee chimiquement et son procede de preparation
|
|
JPS60221091A
(ja)
|
1983-12-21 |
1985-11-05 |
Kyowa Hakko Kogyo Co Ltd |
新規プロモ−タ−
|
|
US5168062A
(en)
|
1985-01-30 |
1992-12-01 |
University Of Iowa Research Foundation |
Transfer vectors and microorganisms containing human cytomegalovirus immediate-early promoter-regulatory DNA sequence
|
|
JP2564268B2
(ja)
|
1985-08-28 |
1996-12-18 |
協和醗酵工業株式会社 |
融合抗原ポリペプチド
|
|
ZA872705B
(en)
|
1986-04-22 |
1987-10-05 |
Immunex Corporation |
Human g-csf protein expression
|
|
JP2958019B2
(ja)
|
1988-05-06 |
1999-10-06 |
住友製薬株式会社 |
ポリエチレングリコール誘導体、修飾ペプチドおよびその製造方法
|
|
JP2928287B2
(ja)
|
1988-09-29 |
1999-08-03 |
協和醗酵工業株式会社 |
新規ポリペプチド
|
|
JPH02257891A
(ja)
|
1989-03-31 |
1990-10-18 |
Kyowa Hakko Kogyo Co Ltd |
組換え動物細胞による蛋白質の製造
|
|
JPH0322979A
(ja)
|
1989-06-19 |
1991-01-31 |
Kyowa Hakko Kogyo Co Ltd |
新規プラスミノーゲン活性化因子
|
|
JP3131322B2
(ja)
|
1991-12-17 |
2001-01-31 |
協和醗酵工業株式会社 |
新規α２→３シアリルトランスフェラーゼ
|
|
US6042828A
(en)
|
1992-09-07 |
2000-03-28 |
Kyowa Hakko Kogyo Co., Ltd. |
Humanized antibodies to ganglioside GM2
|
|
EP0643132B1
(en)
|
1993-03-29 |
2006-05-31 |
Kyowa Hakko Kogyo Co., Ltd. |
Alpha-1,3-fucosyltransferase
|
|
US5705614A
(en)
|
1993-04-09 |
1998-01-06 |
Chiron Corporation |
Methods of producing antigen forks
|
|
JPH11507535A
(ja)
|
1995-06-07 |
1999-07-06 |
イムクローン システムズ インコーポレイテッド |
腫瘍の成長を抑制する抗体および抗体フラグメント類
|
|
AU690474B2
(en)
|
1995-09-11 |
1998-04-23 |
Kyowa Hakko Kirin Co., Ltd. |
Antibody againts alpha-chain of human interleukin 5 receptor
|
|
US6001358A
(en)
|
1995-11-07 |
1999-12-14 |
Idec Pharmaceuticals Corporation |
Humanized antibodies to human gp39, compositions containing thereof
|
|
DK0979281T3
(da)
|
1997-05-02 |
2005-11-21 |
Genentech Inc |
Fremgangsmåde til fremstilling af multispecifikke antistoffer med heteromultimere og fælles bestanddele
|
|
US6235883B1
(en)
|
1997-05-05 |
2001-05-22 |
Abgenix, Inc. |
Human monoclonal antibodies to epidermal growth factor receptor
|
|
US6528624B1
(en)
|
1998-04-02 |
2003-03-04 |
Genentech, Inc. |
Polypeptide variants
|
|
US6737056B1
(en)
|
1999-01-15 |
2004-05-18 |
Genentech, Inc. |
Polypeptide variants with altered effector function
|
|
KR100940380B1
(ko)
|
1999-01-15 |
2010-02-02 |
제넨테크, 인크. |
효과기 기능이 변화된 폴리펩티드 변이체
|
|
PT1176195E
(pt)
|
1999-04-09 |
2013-07-18 |
Kyowa Hakko Kirin Co Ltd |
Processo para controlar a actividade de uma molécula funcional sob o ponto de vista imunológico
|
|
AU2001247616B2
(en)
|
2000-04-11 |
2007-06-14 |
Genentech, Inc. |
Multivalent antibodies and uses therefor
|
|
WO2001092340A2
(en)
*
|
2000-05-26 |
2001-12-06 |
Immunex Corporation |
Use of interleukin-4 antagonists and compositions thereof
|
|
MXPA02012867A
(es)
|
2000-06-29 |
2003-09-05 |
Abbott Lab |
Anticuerpos de especificidad doble y metodos para la elaboracion y el uso de los mismos.
|
|
DK2314686T4
(da)
|
2000-10-06 |
2023-08-21 |
Kyowa Kirin Co Ltd |
Celler, der danner antistofsammensætninger
|
|
CN1571797A
(zh)
|
2001-10-15 |
2005-01-26 |
麒麟麦酒株式会社 |
抗hla－dr抗体
|
|
US7317091B2
(en)
|
2002-03-01 |
2008-01-08 |
Xencor, Inc. |
Optimized Fc variants
|
|
AU2004279742A1
(en)
|
2003-10-08 |
2005-04-21 |
Kyowa Hakko Kirin Co., Ltd. |
Fused protein composition
|
|
CA2580981C
(en)
|
2004-09-22 |
2013-10-22 |
Kirin Beer Kabushiki Kaisha |
Stabilized human igg4 antibodies
|
|
US7923538B2
(en)
|
2005-07-22 |
2011-04-12 |
Kyowa Hakko Kirin Co., Ltd |
Recombinant antibody composition
|
|
US7612181B2
(en)
|
2005-08-19 |
2009-11-03 |
Abbott Laboratories |
Dual variable domain immunoglobulin and uses thereof
|
|
ES2828627T3
(es)
*
|
2008-04-25 |
2021-05-27 |
Kyowa Kirin Co Ltd |
Anticuerpo multivalente estable
|
|
WO2010054007A1
(en)
*
|
2008-11-07 |
2010-05-14 |
Fabrus Llc |
Combinatorial antibody libraries and uses thereof
|
|
RU2011151069A
(ru)
*
|
2009-05-15 |
2013-06-20 |
Чугаи Сейяку Кабусики Кайся |
Анти-axl антитело
|
|
EP2441831B9
(en)
|
2009-06-11 |
2019-03-06 |
Inter-University Research Institute Corporation Research Organization of Information and Systems |
Process for production of protein
|
|
WO2011116387A1
(en)
|
2010-03-19 |
2011-09-22 |
Tetragenetics, Inc. |
Production of aglycosylated monoclonal antibodies in ciliates
|
|
WO2012075037A1
(en)
|
2010-11-30 |
2012-06-07 |
Genentech, Inc. |
Low affinity blood brain barrier receptor antibodies and uses therefor
|
|
WO2012145469A1
(en)
|
2011-04-19 |
2012-10-26 |
The United States Of America, As Represented By The Secretary, Department Of Health & Human Services |
Human monoclonal antibodies specific for glypican-3 and use thereof
|
|
CN103534272B
(zh)
|
2011-05-09 |
2016-05-11 |
株式会社英仙蛋白质科学 |
能够特异性识别转铁蛋白受体的抗体
|
|
US8691231B2
(en)
|
2011-06-03 |
2014-04-08 |
Merrimack Pharmaceuticals, Inc. |
Methods of treatment of tumors expressing predominantly high affinity EGFR ligands or tumors expressing predominantly low affinity EGFR ligands with monoclonal and oligoclonal anti-EGFR antibodies
|
|
PT2794905T
(pt)
|
2011-12-20 |
2020-06-30 |
Medimmune Llc |
Polipéptidos modificados para estrutura de anticorpos bispecíficos
|
|
NZ631565A
(en)
|
2012-03-14 |
2016-07-29 |
Regeneron Pharma |
Multispecific antigen-binding molecules and uses thereof
|
|
MX374424B
(es)
|
2012-05-21 |
2025-03-06 |
Genentech Inc |
Metodos para mejorar la seguridad del transporte de la barrera hematoencefalica.
|
|
EA038367B1
(ru)
|
2013-05-20 |
2021-08-16 |
Дженентек, Инк. |
АНТИТЕЛА ПРОТИВ РЕЦЕПТОРА ТРАНСФЕРРИНА (TfR) И СПОСОБЫ ИХ ИСПОЛЬЗОВАНИЯ
|
|
CN104211814A
(zh)
|
2013-05-29 |
2014-12-17 |
三星电子株式会社 |
用于消耗靶膜蛋白的组合物
|
|
AU2014358191B2
(en)
*
|
2013-12-04 |
2020-12-24 |
Chugai Seiyaku Kabushiki Kaisha |
Antigen-binding molecules, the antigen-binding activity of which varies according to the concentration of compounds, and libraries of said molecules
|
|
JP2017511381A
(ja)
*
|
2014-04-04 |
2017-04-20 |
協和発酵キリン株式会社 |
アゴニスト活性が低減された抗デスレセプター３（ｄｒ３）アンタゴニスト抗体
|
|
WO2016081640A1
(en)
*
|
2014-11-19 |
2016-05-26 |
Genentech, Inc. |
Anti-transferrin receptor / anti-bace1 multispecific antibodies and methods of use
|
|
JP6779876B2
(ja)
*
|
2014-11-19 |
2020-11-04 |
ジェネンテック， インコーポレイテッド |
抗トランスフェリン受容体抗体及びその使用方法
|
|
EP3243837A4
(en)
*
|
2015-01-08 |
2018-12-05 |
Kyowa Hakko Kirin Co., Ltd. |
Bispecific antibody binding to trailr2 and psma
|
|
CR20210429A
(es)
*
|
2015-06-24 |
2021-09-24 |
Hoffmann La Roche |
ANTICUERPOS ANTI-RECEPTOR DE TRANSFERRINA CON AFINIDAD DISEÑADA (Divisional 2017-0562)
|
|
EP3323832A4
(en)
*
|
2015-07-15 |
2018-12-26 |
Kyowa Hakko Kirin Co., Ltd. |
Antibody which specifically binds to human crth2
|
|
EP3454901A4
(en)
|
2016-05-09 |
2020-07-29 |
Annexon, Inc. |
COMPOSITIONS AND METHODS FOR TREATING PROGRESSIVE SPINAL AMYOTROPHY
|
|
KR102156626B1
(ko)
|
2018-07-16 |
2020-09-17 |
주식회사 셀바스에이아이 |
운동 처방 정보를 제공하는 서버 및 컴퓨터 프로그램
|